SB3423 removes a specific FDA shell-egg temperature/time requirement (21 C.F.R. §118.4(e)) for surplus broiler hatching eggs that will be sold to commercial egg breakers, and it directs HHS/FDA, in consultation with USDA, to rewrite the regulation within 180 days to permit holding conditions compatible with hatching. The bill narrowly targets surplus eggs produced for broiler hatcheries and defines key terms such as “egg breaker” and “broiler hatching egg.”
The measure is designed to expand the pool of eggs available for conversion into liquid egg products and reduce waste, which sponsors say could lower retail and ingredient prices. It also shifts an important part of the food-safety equation: eggs held under conditions used for incubation will be processed under the Egg Products Inspection Act, creating different inspection and control points and raising practical questions about microbial risk management, interagency roles, and chain-of-custody requirements.
At a Glance
What It Does
The bill excludes surplus broiler hatching eggs destined for egg breakers from a specific FDA shell-egg refrigeration provision and requires HHS/FDA to issue a revised regulation within 180 days to allow holding at temperatures used for hatching. It leaves cooked and liquid egg products subject to the Egg Products Inspection Act.
Who It Affects
Broiler hatcheries that generate surplus hatching eggs, commercial egg breakers (liquid-egg processors), FDA and USDA regulatory programs, and downstream food manufacturers that buy bulk liquid egg. Retail shell-egg producers may see indirect market effects.
Why It Matters
This creates a legal pathway to convert hatching-intended eggs into food-processing inputs without meeting current shell-egg refrigeration rules, changing how temperature/time controls and inspection interplay across agencies and altering supply dynamics for liquid-egg products.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
Commercial broiler operations periodically produce more fertilized eggs than they will place in incubators; those surplus eggs are the target of this bill. Under existing FDA shell-egg rules, eggs intended for human consumption must meet specified time-and-temperature handling that conflicts with the warmer, controlled environments used by hatcheries.
SB3423 instructs regulators to allow those surplus hatching eggs to be handled in ways compatible with incubation so they can be sold to egg breakers, which then convert them into pasteurized liquid egg products.
Practically speaking, that means two different safety systems will need to link: the hatchery’s handling and documentation chain and the egg breaker’s USDA-regulated processing controls. Egg breakers already operate under the Egg Products Inspection Act and implement pasteurization and Hazard Analysis and Critical Control Point (HACCP) systems; the bill relies on that downstream processing to manage food-safety risks that warmer holding conditions could increase.
The required FDA rulemaking will need to define allowable holding temperatures, maximum holding periods, and identification or segregation standards so processors can demonstrate eggs were intended for breaking, not retail shell sale.The 180-day timeframe presses agencies to produce an operational rule quickly, but the technical work will be detailed: establishing time-temperature combinations that balance viability for hatching with limits on bacterial growth, determining documentation and traceability requirements to prevent diversion into the shell-egg market, and assigning inspection responsibilities between FDA and USDA. Stakeholders—hatcheries, breakers, and regulators—will therefore need to establish chain-of-custody protocols, testing expectations, and likely new recordkeeping systems before the pathway becomes routine.Beyond the operational changes, the policy effect is straightforward: by increasing the volume of eggs eligible for conversion to liquid products, the bill aims to expand supply and put downward pressure on prices for liquid eggs and possibly some shell-egg substitute markets.
Whether savings reach consumers depends on how quickly the supply increase materializes, how processors price the additional input, and how retail markets respond to any change in available shell-egg supply.
The Five Things You Need to Know
SB3423 makes 21 C.F.R. §118.4(e) inapplicable to surplus broiler hatching eggs sold to egg breakers, effective on enactment.
The bill directs the HHS Secretary, through the FDA Commissioner and consulting with USDA, to revise 21 C.F.R. §118.4 within 180 days to permit holding conditions compatible with hatching.
It explicitly leaves liquid egg products subject to the Egg Products Inspection Act (USDA jurisdiction) and defines ‘egg breaker,’ ‘broiler hatching egg,’ and ‘broiler hatchery’ for the new regulatory framework.
The revised regulation must allow holding at temperatures and for periods that permit hatching operations—shifting the applicable time–temperature controls away from current shell-egg refrigeration rules.
Because the path depends on sale to egg breakers, the bill creates a traceability/segregation trigger: only eggs intended for processing as liquid products are exempt from the shell-egg provision.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title: Lowering Egg Prices Act of 2025
A one-line naming provision that brands the measure. While purely formal, the short title signals the sponsor’s stated policy goal—affecting how stakeholders and regulators frame subsequent rulemaking and compliance priorities.
Temporary inapplicability of 21 C.F.R. §118.4(e) to surplus broiler hatching eggs
This clause removes the applicability of the cited FDA shell-egg rule specifically for surplus broiler hatching eggs sold to egg breakers, effective on enactment. Mechanically, it creates an immediate carve-out: until the FDA issues a revised rule, surplus hatching eggs intended for breaking are not subject to the specified shell-egg refrigeration requirement. That immediate inapplicability could allow transactions to proceed under hatchery conditions right away, raising practical questions about how processors document the exemption and whether interim enforcement guidance will be issued.
Mandatory FDA rulemaking with USDA consultation (180-day deadline)
The bill requires the HHS Secretary (through the FDA Commissioner), consulting with USDA, to revise the relevant regulation within 180 days. The revision must permit holding at temperatures and for durations compatible with hatching. This imposes a firm statutory deadline and a consultation duty—both intended to force a technical regulatory fix. The rule will need to be precise: it must set binding time–temperature tolerances, recordkeeping and labeling requirements to preclude diversion into the shell-egg market, and clarify enforcement roles between FDA and USDA.
Definitions specific to the exemption
The bill defines ‘egg,’ ‘egg product,’ ‘egg breaker,’ ‘broiler hatching egg,’ and ‘broiler hatchery,’ tying the exemption to commercial hatchery-generated eggs and commercial breakers. Because the carve-out uses those definitions, the text limits the exemption to clearly commercial supply chains and provides a statutory baseline for any regulatory definitions in the forthcoming FDA rule.
This bill is one of many.
Codify tracks hundreds of bills on Agriculture across all five countries.
Explore Agriculture in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Broiler hatcheries — can monetize surplus hatching eggs that otherwise might be wasted or sold at lower value, improving asset utilization and reducing disposal costs by selling eggs directly to breakers under hatch-compatible conditions.
- Commercial egg breakers (liquid-egg processors) — gain access to an expanded supply of eggs potentially at lower input cost, helping capacity utilization and lowering ingredient costs for food manufacturers that buy bulk liquid egg.
- Food manufacturers and downstream buyers of liquid egg — could see lower ingredient prices if processors pass on cost savings, especially in industries that use pasteurized liquid egg at scale (bakery, prepared foods).
- Consumers (indirectly) — may benefit from lower retail prices for processed foods and potentially reduced shell-egg price pressure if processors’ increased supply reduces demand for shell eggs used in manufacturing.
- Poultry supply chain efficiency advocates — reduced waste and better matching of production to demand can lower overall industry disposal costs and improve margins across hatch-to-farm operations.
Who Bears the Cost
- FDA and USDA regulatory programs — must coordinate technically and administratively to draft, implement, and enforce the new rule, likely requiring staff time, joint guidance, and potentially new inspection protocols.
- Broiler hatcheries — must implement traceability, segregation, and documentation processes to establish which surplus eggs are destined for breaking versus shell sale, and may incur costs to modify handling practices to meet both hatch and food-safety requirements.
- Smaller shell-egg producers and niche producers — could face increased price competition if liquid-egg input markets shift or if larger processors leverage new supply to cut prices, squeezing margins for smaller operators.
- Egg breakers/processors — while benefiting from more supply, they may face higher testing, monitoring, and liability risks if warmer holding increases pathogen loads, necessitating expanded HACCP controls, testing, or insurance costs.
- State and local public-health agencies — may see increased pressure to respond to novel supply-chain incidents or to coordinate on enforcement when eggs move between hatchery conditions and food-processing channels.
Key Issues
The Core Tension
The central dilemma is supply versus safety: the bill increases the usable egg supply—and the potential for lower prices—by allowing hatch-compatible holding, but that same holding environment favors bacterial growth; the policy therefore substitutes downstream processing controls and traceability for preventative cold-chain measures, creating a real trade-off between reducing waste and preserving the pre-processing controls that limit foodborne illness risk.
The bill resolves an access problem—hatchery-compatible temperatures versus shell-egg refrigeration—by shifting the compliance hinge from pre-processing controls to downstream processing regulatory controls. That shift depends on two assumptions: first, that egg breakers’ pasteurization and HACCP systems reliably mitigate elevated microbial risk that could occur during warmer holding; second, that chain-of-custody, labeling, and recordkeeping will be adequate to prevent diversion of eggs intended for shell sale into the exemption.
Neither assumption is guaranteed in practice and both require precise regulatory definitions and enforcement strategies.
Operationally and legally, the measure creates an interagency coordination challenge. FDA currently prescribes shell-egg handling; USDA inspects egg products.
The bill forces FDA to rewrite a regulation while explicitly requiring consultation with USDA, but it does not specify who enforces traceability or how penalties apply if eggs are misdirected. The 180-day deadline compresses complex scientific and administrative work into a short window, raising the risk that the resulting rule will need rapid revisions once implemented.
Finally, the public-health trade-offs depend heavily on downstream practices—if processors expand pasteurization and testing, risks can be managed; if they rely on minimal additional controls, pathogen risks could rise despite regulatory oversight.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.